RhPV as a model for HPV-induced cancers

Details RhPV as a model for HPV-induced cancers RhPV as a model for HPV-induced cancers

2007-10-23

2007-10-23

Salimi, Ali R. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S325000

Reexamination Certificate

active

10978239

ABSTRACT:
Provided is an animal model system for the study of papillomaviruses, especially anogenital papillomaviruses, especially those causing anogenital and/or head and neck cancers. The Rhesus papillomavirus (especially RhPV1) is a useful model for human papillomaviruses which cause anogenital infections and cancers of the anogenital region and/or the head, neck and respiratory system.

REFERENCES:
patent: 5994115 (1999-11-01), Meyers
patent: 6110663 (2000-08-01), Meyers et al.
patent: 6399353 (2002-06-01), Meyers et al.
patent: 6495361 (2002-12-01), Hermonat et al.
patent: 6596924 (2003-07-01), Jianmin
patent: 6797491 (2004-09-01), Neefe et al.
Chan et al. (Jul. 1997) “Genomic Diversity and Evolution of Papillomaviruses in Rhesus Monkeys,”J. Virol. 71(7):4938-4943.
Debattista et al. (Jun. 2003) “Immunopathogenesis ofChlamydia trachomatisInfections in Women,”Fertility and Sterility79:1273-1287.
Howley, P.M. (1996) “Papillomavirinae: The Viruses and Their Replication,” In; B.N. Fields et al. eds.,Fields Virology, Third Edition, Second ed. Raven Press, New York, pp. 2045-2076.
Gillison et al. (May 2000) “Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers,”J. Nat. Canc. Inst.92:709-720.
Kloster et al. (May 1988) “Molecular Cloning and Characterization of the DNA of two Papillomaviruses from Monkeys,”Virol. 166:30-40.
Lin et al. (Sep. 2002) “Chaperone Proteins Abrogate Inhibition of the Human Papillomavirus (HPV) E1 Replicative Helicase by the HPV E2 Protein,”Mol. Cell Biol.22:6592-6604.
Liu et al. (Nov. 1998) “Human Hsp70 and Hsp40 Chaperone Proteins Facilitate Human Papillomavirus-11 E1 Protein Binding to the Origin and Stimulate Cell-free DNA Replication,”J. Biol. Chem.273(13):30704-30712.
Morozov et al. (1995) “HPV16 E7 Oncoprotein Induces Expression of a 110 kDa Heat Shock Protein,”FEBS Lett. 371:214-218.
Myers et al. (Oct. 1997) “Synthesis of Infectious Human Papillomavirus Type 18 in Differentiating Epithelium Transfected with Viral DNA,”J. Virol. 71(10):7381-7386.
Ostrow et al. (Oct. 1990) “A Rhesus Monkey Model for Sexual Transmission of a Papillomavirus Isolated from a Squamous Cell Carcinoma,”Proc. Natl. Acad. Sci. USA87:8170-8174.
Ostrow et al (1991) “Characterization of the Complete RhPV 1 Genomic Sequence and an Integration Locus from a Metastatic Tumor,”Virol. 181:424-429.
Ozbun, M.A. (Nov. 2002) “Infectious Human Papillomavirus Type 31b: Purification and Infection of an Immortalized Human Keratinocyte Cell Line,”J. Gen. Virol. 83:2753-2763.
Ozbun, M.A. (Nov. 2002) “Human Papillomavirus Type 31b Infection of Human Keratinocytes and the Onset of Early Transcription,”J. Virol. 76:11291-11300.
Ozbun et al. (Apr. 1998) “Temporal Usage of Multiple Promoters During the Life Cycle of Human Papillomavirus Type 31b,”J. Virol. 72:2715-2722.
Ozbun et al. (Apr. 1999) “Two Novel Promoters in the Upstream Regulatory Region of Human Papillomavirus Type 31b are Negatively Regulated by Epithelial Differentiation,”J. Virol. 73:3505-3510.
Schilling et al. (May 1998) “A Novel Human DnaJ Protein, hTid-1, A Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein,”Virol. 247:74-85.
Steele et al. (Aug. 2002) “Variable Expression of Some “Housekeeping” Genes During Human Keratinocyte Differentiation,”Anal. Biochem. 307:341-347.
Sullivan et al. (May 2001) “The Virus-Chaperone Connection,”Virol. 287:1-8.
Walboomers et al. (May 1999) “Human Papillomavirus is a Necessary Cause of Invasive Cervical Cancer Worldwide,”J. Pathol. 189:12-19.
Wood, Charles E, et al., “Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques,” Journal of Virology, (Jun. 2007) vol. 8, No. 12, pp. 6339-6345.

Affiliated with

Also associated with

Rating

RhPV as a model for HPV-induced cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with RhPV as a model for HPV-induced cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RhPV as a model for HPV-induced cancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3893200